Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GLI family zinc finger proteins are DNA-binding transcription factors encoded by GLI1, GLI2, and GLI3 genes. They are central mediators of the Hedgehog signaling pathway, translating extracellular Hedgehog (e.g., Sonic hedgehog/Shh) gradients into gene expression changes. These proteins contain conserved C2-H2 zinc finger domains, enabling sequence-specific DNA recognition and gene regulation. GLI proteins orchestrate embryonic patterning, proliferation, differentiation, and cell survival. Dysregulation is linked to several cancers (e.g., basal cell carcinoma, glioblastoma) and congenital anomalies. As effectors of Hh signaling, GLI proteins are attractive therapeutic targets, particularly for Hh-driven malignancies and genetic disorders
Inhibition of Hedgehog pathway upstream (reduces GLI activation); Direct inhibition of GLI DNA binding or transcriptional activity
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GLI family zinc finger protein (GLI).